DMARGE MAGAZINE: Psychedelics Tycoon JJ Wilson On Psilocybin, MDMA & Australia’s Mental Health Renaissance – Optimi Health OPTI (CNSX)

DMARGE MAGAZINE: Psychedelics Tycoon JJ Wilson On Psilocybin, MDMA & Australia’s Mental Health Renaissance

August 16, 2023
Optimi Health OPTI (CNSX)

Click on Image to Read Full Interview.

ABOUT OPTIMI

(CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FORWARD‐LOOKING STATEMENTS

Optimi Health Corp.

21 Water St #600, Vancouver, BC V6B 1A1

Contact Information

E: investors@optimihealth.ca

T: +778-761-4551

Regulator Filings

Sedar Documents

Legal Counsel: Norton Rose Fulbright

Auditor: Smythe CPA

Transfer Agent: Endeavor Trust

Corporate Visibility & Investor Relations: Kydder Group

Trading Symbol: CSE: OPTI | OTC:OPTHF |

FRA: 8BN

CUSIP Number: 68405H100

ISIN Number: CA68405H1001

WKN: A2QQEL

Issued & Outstanding: (30/06/2022) 80,451,883

Incorporated: BC / May 27, 2020

Year End: September 30th

Product Disclaimer: Optimi Health products are still being investigated through a clinically validated development program for the purpose of applying for market authorization.

The safety and efficacy of our products has not been formally established.

© Copyright 2024 Optimi Health All rights reserved.